---
created: '2026-02-09T05:54:32.695798Z'
description: The pathological process by which alpha-synuclein protein misfolds and
  aggregates into oligomers, fibrils, and Lewy bodies. Central to Parkinson's disease
  and other synucleinopathies.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/pathway/alpha-synuclein-aggregation/
slug: alpha-synuclein-aggregation
tags:
- pathway
- neurodegeneration
- parkinsons
- synucleinopathy
- protein-aggregation
templateEngineOverride: njk
title: Alpha-Synuclein Aggregation
type: pathway
updated: '2026-02-09T05:54:32.695798Z'
---

{% raw %}
<h1>Alpha-Synuclein Aggregation</h1>
<h2>Overview</h2>
<p>Alpha-synuclein aggregation is the central pathological process underlying Parkinson's disease and related synucleinopathies. The normally soluble 140-amino acid protein misfolds and self-assembles into toxic oligomers and insoluble fibrils, which accumulate in neurons as Lewy bodies and Lewy neurites. This process leads to synaptic dysfunction, neuroinflammation, and neuronal death.</p>
<h2>Normal Alpha-Synuclein Function</h2>
<ul>
<li>Concentrated at presynaptic terminals</li>
<li>Regulates synaptic vesicle trafficking</li>
<li>Modulates dopamine release</li>
<li>Interacts with lipid membranes</li>
<li>May function as a chaperone</li>
</ul>
<h2>Aggregation Cascade</h2>
<h3>1. Monomeric State</h3>
<ul>
<li>Native, unfolded protein</li>
<li>Membrane-bound: alpha-helical</li>
<li>Cytoplasmic: intrinsically disordered</li>
</ul>
<h3>2. Oligomer Formation</h3>
<ul>
<li>Misfolded monomers associate</li>
<li><strong>Most toxic species</strong></li>
<li>Membrane permeabilization</li>
<li>Mitochondrial dysfunction</li>
</ul>
<h3>3. Protofibril Stage</h3>
<ul>
<li>Ordered beta-sheet structures</li>
<li>Intermediate aggregates</li>
<li>Seeding capability</li>
</ul>
<h3>4. Mature Fibrils</h3>
<ul>
<li>Insoluble amyloid structures</li>
<li>Cross-beta sheet architecture</li>
<li>May be less acutely toxic than oligomers</li>
</ul>
<h3>5. Lewy Bodies</h3>
<ul>
<li>Dense cytoplasmic inclusions</li>
<li>Surrounded by organelles and cytoskeletal elements</li>
<li>Diagnostic hallmark of PD</li>
</ul>
<h2>Triggers and Risk Factors</h2>
<h3>Genetic</h3>
<ul>
<li><strong>SNCA gene</strong>: Duplications, triplications, point mutations</li>
<li><strong>GBA1 mutations</strong>: Impaired lysosomal function</li>
<li><strong>LRRK2 mutations</strong>: Phosphorylation abnormalities</li>
</ul>
<h3>Environmental</h3>
<ul>
<li>Pesticides (rotenone, paraquat)</li>
<li>Heavy metals</li>
<li>Oxidative stress</li>
</ul>
<h3>Cellular Stress</h3>
<ul>
<li>Mitochondrial dysfunction</li>
<li>Proteasome impairment</li>
<li>ER stress</li>
<li>Aging</li>
</ul>
<h2>Prion-Like Spreading</h2>
<h3>Cell-to-Cell Transmission</h3>
<ol>
<li>Misfolded alpha-synuclein released from neurons</li>
<li>Uptake by neighboring cells</li>
<li>Templated seeding of native protein</li>
<li>Spreading along neuronal networks</li>
</ol>
<h3>Braak Staging</h3>
<ul>
<li>Pathology starts in olfactory bulb and enteric nervous system</li>
<li>Spreads to brainstem (Stage 1-2)</li>
<li>Reaches substantia nigra (Stage 3)</li>
<li>Progresses to cortex (Stage 4-6)</li>
</ul>
<h2>Therapeutic Targets</h2>
<h3>Aggregation Inhibition</h3>
<ul>
<li>Small molecule aggregation inhibitors</li>
<li>Molecular chaperones</li>
<li>Heat shock proteins</li>
</ul>
<h3>Clearance Enhancement</h3>
<ul>
<li>Autophagy activation</li>
<li>Lysosomal function restoration</li>
<li>Ubiquitin-proteasome enhancement</li>
</ul>
<h3>Immunotherapy</h3>
<ul>
<li>Active vaccines (affitope)</li>
<li>Passive immunization (anti-α-syn antibodies)</li>
<li>Prasinezumab, cinpanemab in trials</li>
</ul>
<h3>Gene Therapy</h3>
<ul>
<li>Antisense oligonucleotides</li>
<li>siRNA approaches</li>
<li>SNCA reduction strategies</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ [[Locus_Coeruleus]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_SAA]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Oxidative_Phosphorylation]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dorsal_Raphe_Nucleus]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lewy_Body_Dementia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Enteric_Nervous_System]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[DAT-SPECT]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neurofilament_Light_Chain]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neuron-Derived_Exosome_Biomarkers]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Autophagy-Lysosomal_Pathway]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Parkinsons_Disease]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Blood_NfL]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Multiple_System_Atrophy]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Autophagy_Enhancers]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_CSF]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Substantia_Nigra]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:48:39.358689'
source: obsidian
</code></pre>
<ul>
<li>→ [[Autophagy_Enhancers]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Alpha-Synuclein_CSF]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Autophagy-Lysosomal_Pathway]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Enteric_Nervous_System]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Oxidative_Phosphorylation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Lewy_Body_Dementia]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neuroinflammation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Multiple_System_Atrophy]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>← [[DAT-SPECT]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.395203'
source: obsidian
</code></pre>
<ul>
<li>← [[Alpha-Synuclein_SAA]] (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.082636'
source: obsidian
</code></pre>
<ul>
<li>← [[Parkinsons_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:35.297115'
source: obsidian
</code></pre>
<ul>
<li>← [[Neuron-Derived_Exosome_Biomarkers]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:15.353378'
source: obsidian
</code></pre>
<ul>
<li>← [[Blood_NfL]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>← [[Neuroinflammation]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:12.428247'
source: obsidian
</code></pre>
<ul>
<li>← [[Autophagy-Lysosomal_Pathway]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:11.341134'
source: obsidian
</code></pre>
<ul>
<li>→ [[Dorsal_Raphe_Nucleus]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Substantia_Nigra]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Mitophagy]] (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Locus_Coeruleus]] (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Exercise]] (intervention)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Neurofilament_Light_Chain]] (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<ul>
<li>→ [[Parkinsons_Disease]] (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:08:10.957081'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Associated Diseases</h3>
<ul>
<li>→ [[Parkinson's Disease]] (condition) - <em>Hallmark pathology</em></li>
<li>→ [[Lewy Body Dementia]] (condition) - <em>Cortical Lewy bodies</em></li>
<li>→ [[Multiple System Atrophy]] (condition) - <em>Glial cytoplasmic inclusions</em></li>
</ul>
<h3>Brain Regions Affected</h3>
<ul>
<li>→ [[Substantia Nigra]] (organ) - <em>Dopamine neuron loss</em></li>
<li>→ [[Locus Coeruleus]] (organ) - <em>Noradrenergic loss</em></li>
<li>→ [[Dorsal Raphe Nucleus]] (organ) - <em>Serotonergic involvement</em></li>
<li>→ [[Enteric Nervous System]] (organ) - <em>Early involvement</em></li>
</ul>
<h3>Contributing Pathways</h3>
<ul>
<li>← [[Mitophagy]] (pathway) - <em>Impaired mitochondrial clearance</em></li>
<li>← [[Oxidative Phosphorylation]] (pathway) - <em>Mitochondrial dysfunction</em></li>
<li>← [[Autophagy-Lysosomal Pathway]] (pathway) - <em>Clearance failure</em></li>
<li>← [[Neuroinflammation]] (pathway) - <em>Microglial activation</em></li>
</ul>
<h3>Biomarkers</h3>
<ul>
<li>→ [[Alpha-Synuclein CSF]] (biomarker) - <em>Diagnostic potential</em></li>
<li>→ [[Neurofilament Light Chain]] (biomarker) - <em>Neurodegeneration marker</em></li>
</ul>
<h3>Therapeutic Interventions</h3>
<ul>
<li>← [[Exercise]] (intervention) - <em>May reduce aggregation</em></li>
<li>← [[Autophagy Enhancers]] (intervention) - <em>Clearance support</em></li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Pathology</strong>: Spillantini, M.G., et al. (1997). &quot;Alpha-synuclein in Lewy bodies.&quot; <em>Nature</em>.</li>
<li><strong>Prion-like Spreading</strong>: Braak, H., et al. (2003). &quot;Staging of brain pathology related to sporadic PD.&quot; <em>Neurobiology of Aging</em>.</li>
<li><strong>Therapeutics</strong>: Brundin, P., et al. (2017). &quot;Therapeutic approaches to α-synuclein pathology.&quot; <em>Experimental Neurology</em>.</li>
</ol>

{% endraw %}